PFC, Tech Mahindra and Dr. Reddy's to see some action today

12 Mar 2021 Evaluate

Power Finance Corporation (PFC) and REC have entered into a pact with Bhutan-based Kholongchhu Hydro Energy (KHEL) to finance a 600-megawatt hydroelectric project at Trashiyangtse in the neighbouring country. KHEL is a 50:50 joint venture between SJVN India and Druk Green Power Corporation (Bhutan) set up for developing the 600-MW Kholongchhu hydroelectric project in the eastern Bhutan.

Tech Mahindra has achieved System and Organization Control (SOC) 2 Type 2 attestation for BPS and IT services. The SOC 2 report reinforces Tech Mahindra’s commitment towards safeguarding customers security, privacy, availability and confidentiality across all services globally. Tech Mahindra continues to demonstrate its focus on customer trust, loyalty and quality in business operations.

Dr. Reddy's Laboratories’ API manufacturing plant at New York has received three observations from United States Food and Drug Administration (USFDA). The audit of API manufacturing plant at Middleburg, New York has been completed by the USFDA. The company will address three observations comprehensively within the stipulated timeline. Currently, the company does not have any sales from this plant.

Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has acquired 428,571 ordinary shares (equivalent to 12.5% fully diluted equity stake) of WRS Bioproducts Pty. by making the payment of Australian dollar (AUD) 2.0 million and complying with all requirements.

NBCC (India) has executed Memorandum of Understanding (MoU) with National Institute of Technology, Patna for supervision of construction & development of institute campus, hostel and residential buildings, etc. at NIT Patna (Bihta Campus).  NBCC is the Project Management Consultant for this project of value Rs 468 crore approximately.

Prestige Estates Projects has completed phase 1 of proposed transaction with Blackstone Group. The enterprise value forming part of phase 1 is approximately Rs 74,670 million out of the total enterprise value of approximately Rs 91,600 Million. Phase 1 of the transaction includes sale of twelve assets/undertakings comprising of completed retail, office and hotel assets. Phase 2 of the transaction is expected to get completed by the end of next Quarter.

Karur Vysya Bank and Cholamandalam Investment and Finance Company (Chola), the financial services arm of the Murugappa Group, have successfully launched Co-lending business in partnership. The co-lending model is a great opportunity for banks and NBFCs to draw upon each other’s strengths.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×